See how top analysts and institutions rate CIFR — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| JP Morgan | Upgrade | Neutral → Overweight | $18 | 2025-11-24 |
| Citizens JMP | Initiated | Mkt Outperform | $30 | 2025-11-19 |
| Arete | Initiated | Buy | $24 | 2025-09-24 |
| Compass Point | Resumed | Buy | 2025-09-15 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| December 2025 | 4 | 9 | 0 | 0 | 0 |
| November 2025 | 4 | 9 | 1 | 0 | 0 |
| October 2025 | 3 | 8 | 2 | 0 | 0 |
| September 2025 | 3 | 8 | 2 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CIFR, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
